Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Charles River Laboratories Intl
(NY:
CRL
)
208.00
-0.44 (-0.21%)
Streaming Delayed Price
Updated: 10:49 AM EDT, Jun 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Charles River Laboratories Intl
< Previous
1
2
3
4
5
6
7
Next >
Charles River Laboratories Announces Third-Quarter 2023 Results
November 08, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Launches Real-Time Research Model Ordering, Introducing an Important Digital Innovation to Research Models & Services Business
October 19, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Schedules Third-Quarter 2023 Earnings Release and Conference Call
October 16, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Provides Access to Relevant, Well-Characterized Pediatric PDX Collection for Oncology Research
October 16, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Achieves 90% Renewable Electricity Globally, Announces Progress on Environmental Goals
October 11, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Unveils Lentivation Platform to Expedite LVV-based Gene Therapy Manufacturing
September 26, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Announces Opening of RightSourceSM Laboratory, Supporting Stevenage Biocluster
September 25, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories International, Inc. (NYSE: CRL) Long Term Investor Alert: Investigation of Potential Wrongdoing
September 22, 2023
San Diego, CA -- (SBWIRE) -- 09/22/2023 -- Certain directors of Charles River Laboratories International, Inc are under investigation concerning potential breaches of fiduciary duties.
Via
SBWire
Charles River Laboratories to Host Virtual Investor Day
September 20, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River and Related Sciences Enter Multi-Program Collaboration to Pursue AI-Enabled Drug Discovery Utilizing Logica
September 14, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
September 11, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River and PathoQuest Announce Publication of a Head-to-Head Study Validating Proprietary Next Generation Sequencing Viral Safety Assay as a Reliable In Vitro Alternative to Animal Testing Methods
September 06, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Announces Plasmid Manufacturing Collaboration with Fondazione Telethon
August 24, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
August 22, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Charles River Laboratories Announces Second-Quarter 2023 Results
August 09, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Expands Access to AAALAC-Accredited, Turnkey Research Space in Key Markets
August 01, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Schedules Second-Quarter 2023 Earnings Release and Conference Call
July 19, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Charles River Laboratories International, Inc. (CRL)
July 17, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
CRL FINAL DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Charles River Laboratories International, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important July 18 Deadline in Securities Class Action – CRL
July 17, 2023
From
The Rosen Law Firm PA
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stem, Disney, Charles River, and Virtu and Encourages Investors to Contact the Firm
July 16, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
CRL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Charles River Laboratories International, Inc. Investors to Secure Counsel Before Important July 18 Deadline in Securities Class Action - CRL
July 16, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Law Enforcement
Lawsuit
Exposures
Financial
Legal
CHARLES RIVER 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Charles River Laboratories International, Inc. - CRL
July 14, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
ROSEN, A LEADING NATIONAL FIRM, Encourages Charles River Laboratories International, Inc. Investors to Secure Counsel Before Important July 18 Deadline in Securities Class Action - CRL
July 14, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Law Enforcement
Lawsuit
Exposures
Financial
Legal
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (NYSE: CRL) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Charles River Laboratories
July 11, 2023
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stem, Disney, Virtu, and Charles River and Encourages Investors to Contact the Firm
July 10, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, A RANKED AND LEADING FIRM, Encourages Charles River Laboratories International, Inc. Investors to Secure Counsel Before Important July 18 Deadline in Securities Class Action - CRL
July 09, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Law Enforcement
Lawsuit
Exposures
Financial
Legal
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Charles River Laboratories International, Inc. Investors to Secure Counsel Before Important July 18 Deadline in Securities Class Action - CRL
July 07, 2023
WHY: New York, NY - (NewMediaWire) - July 07, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Charles River Laboratories International, Inc. (NYSE:...
Via
NewMediaWire
Topics
Law Enforcement
Lawsuit
Exposures
Financial
Legal
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Charles River Laboratories International, Inc. Investors to Secure Counsel Before Important July 18 Deadline in Securities Class Action - CRL
July 06, 2023
WHY: New York, NY - (NewMediaWire) - July 06, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Charles River Laboratories International, Inc. (NYSE:...
Via
NewMediaWire
Topics
Law Enforcement
Lawsuit
Exposures
Financial
Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stem, Disney, Charles River, and Virtu and Encourages Investors to Contact the Firm
July 05, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
SHAREHOLDER CLASS ACTION REMINDER: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Charles River Laboratories International, Inc. (NYSE: CRL)
July 05, 2023
From
Bernstein Liebhard LLP
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.